Chronic lung sufferers call for an end to stand-off on access to ’life-changing’ drug

Patients with genetic emphysema are calling for an end to the current stand-off on what they say is a life-changing drug.

Chronic lung sufferers call for an end to stand-off on access to ’life-changing’ drug

Patients with genetic emphysema are calling for an end to the current stand-off on what they claim is a life-changing drug.

They will hold a vigil today before the HSE meets with pharmaceutical company CSL Behring to discuss access to Respreeza.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited